Publication

A biocompatible arginine-based polycation

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Blaine J. Zern, University of PennsylvaniaHunghao Chu, University of PittsburghAdeboye O. Osunkoya, Emory UniversityJin Gao, University of PittsburghYadong Wang, University of Pittsburgh
Language
  • English
Date
  • 2011-02-08
Publisher
  • Wiley: 12 months
Publication Version
Copyright Statement
  • © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1616-301X
Volume
  • 21
Issue
  • 3
Start Page
  • 434
End Page
  • 440
Grant/Funding Information
  • This research is supported by an NSF grant # DMR-1005766.
Supplemental Material (URL)
Abstract
  • Self assembly between cations and anions is ubiquitous throughout nature. Important biological structures such as chromatin often use polyvalent assembly between a polycation and a polyanion. The biomedical importance of synthetic polycations arises from their affinity to polyanions such as nucleic acid and heparan sulfate. However, the limited biocompatibility of synthetic polycations hampers the realization of their immense potential. By examining biocompatible cationic peptides, we hypothesize that a biocompatible polycation should be biodegradable and made from endogenous cations. We design an arginine-based biodegradable polycation and demonstrate that it is more compatible by several orders of magnitude than conventional polycations in vitro and in vivo. This biocompatibility diminishes when L-arginine is substituted with D-arginine or when the biodegradable ester linker is changed to a biostable ether linker. We believe that this design can lead to many biocompatible polycations that can significantly advance a wide range of applications including controlled release, tissue engineering, biosensing, and medical devices. The design of PAGS and the control polymers that probe the importance of endogenous cations and their degradability in terms of biocompatibility is studied. The biocompatibility is shown to diminish when L-arginine is substituted with D-arginine or when the biodegradable ester linker is changed to a biostable ether linker.
Author Notes
  • Yadong Wang: yaw20@pitt.edu Tel: (412) 624 - 7196 Fax: (412) 383 – 8788.
Research Categories
  • Engineering, Biomedical
  • Health Sciences, Pathology

Tools

Relations

In Collection:

Items